Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Acinar Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05481476
What this trial is testing

Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sun Yat-sen University 32
Early research (Phase 1)Not Yet RecruitingNCT07707674
What this trial is testing

Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Evopoint Biosciences Inc. 24
Large-scale testing (Phase 3)Looking for participantsNCT07219238
What this trial is testing

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Who this might be right for
Colorectal CancerGastric CancersOvarian Cancers+1 more
GE Healthcare 175
Not applicableApproved For MarketingNCT00786058
What this trial is testing

A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

Who this might be right for
Pancreatic Cancer
CONKO-Studiengruppe
Not applicableLooking for participantsNCT06287749
What this trial is testing

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

Who this might be right for
Pancreatic Cancer ResectablePancreatic Ductal AdenocarcinomaMinimal Residual Disease+2 more
University Hospital, Montpellier 37
Not applicableNot Yet RecruitingNCT07839676
What this trial is testing

A Prospective Study of Concurrent Hyperthermia, Chemotherapy and Radiotherapy in Borderline and Locally Advanced Pancreatic Cancer (PANHEAT)

Who this might be right for
Borderline and Locally Advanced Pancreatic Cancer
Fernando Pessoa Canarias University 60
Testing effectiveness (Phase 2)Study completedNCT02403271
What this trial is testing

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerBreast CancerPancreatic Cancer
Pharmacyclics LLC. 124
Testing effectiveness (Phase 2)Study completedNCT00005926
What this trial is testing

Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas

Who this might be right for
Pancreatic CancerPancreatic Neoplasm
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Ended earlyNCT06630325
What this trial is testing

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+11 more
OHSU Knight Cancer Institute 6
Not applicableStudy completedNCT06118125
What this trial is testing

Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement

Who this might be right for
Neoplasms, ColorectalGeneral PractitionerPandemic, COVID-19+4 more
University of Bordeaux 376
Not applicableUnknownNCT02550847
What this trial is testing

Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Taiwan University Hospital 100
Early research (Phase 1)UnknownNCT05088889
What this trial is testing

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

Who this might be right for
Stage IV Pancreatic Cancer
Sheba Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00025168
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Wake Forest University Health Sciences 20
Not applicableStudy completedNCT05132868
What this trial is testing

Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling

Who this might be right for
QualityProstate CancerGastrointestinal Cancer+3 more
Stanford University 78
Not applicableStudy completedNCT04317352
What this trial is testing

Multivisceral Resection in Distal Pancreatectomy

Who this might be right for
Pancreatic NeoplasmsSurgical Procedure, Unspecified
Universidad de Extremadura 435
Testing effectiveness (Phase 2)UnknownNCT04571489
What this trial is testing

A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Lee's Pharmaceutical Limited 60
Not applicableEnded earlyNCT02900248
What this trial is testing

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice

Who this might be right for
NeoplasmsLung NeoplasmsColon Neoplasms+22 more
CureOne 23
Testing effectiveness (Phase 2)Ended earlyNCT03469258
What this trial is testing

Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Dana-Farber Cancer Institute 4
Testing effectiveness (Phase 2)UnknownNCT04449289
What this trial is testing

Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery

Who this might be right for
Pancreatic Cancer
Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor 100
Not applicableEnrolling By InvitationNCT07697170
What this trial is testing

Frequency of Care for Peripherally Inserted Central Vascular Access In the Prevention of Marsi

Who this might be right for
Colon CancerCancer Pancreas
Institut Català d'Oncologia 150
Next Page